SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., a developer of pioneering technologies to empower science, today announced that Element CEO and co-founder Molly He will be presenting a corporate update at the 43rd annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will take place at 8:30am PT on Monday, January 13, 2025, at The Westin St. Francis Hotel.
About Element Biosciences, Inc.
Element Biosciences is a multi-disciplinary life science company focused on developing disruptive DNA sequencing technology for research markets. Through innovating every fundamental element of a sequencing system, Element empowers customers with affordable, high-quality data and an improved user experience, which in turn will accelerate scientific discoveries and broaden the use of genomic research. To learn more about Element, please visit www.elementbiosciences.com.
